{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:04Z","timestamp":1792784824011,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14084-x","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:37:29Z","timestamp":1785220649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence of Toxoplasma gondii infection, associated risk factors, and circulating IL-6 and VEGF-A levels in colorectal cancer patients: a case\u2013control study from western Iran"],"prefix":"10.1186","volume":"26","author":[{"given":"Alireza","family":"Moayyedkazemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hematpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Khudair Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Ahmadi Somaghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Sepahvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Baharvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Mahmoudvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"3","key":"14084_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"3","key":"14084_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.14309\/ajg.0000000000001122","volume":"116","author":"A Shaukat","year":"2021","unstructured":"Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG clinical guidelines: colorectal cancer screening 2021. Official J Am Coll Gastroenterology| ACG. 2021;116(3):458\u201379.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"10207","key":"14084_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380.","journal-title":"Lancet"},{"issue":"1","key":"14084_CR4","first-page":"1","volume":"6","author":"H Mahmoudvand","year":"2011","unstructured":"Mahmoudvand H, Mohebali M, Sharifi I, Zarean M, Javadi A. Epidemiological aspects of Visceral leishmaniasis in Baft district, Kerman Province, Southeast of Iran. Iran J Parasitol. 2011;6(1):1\u201311.","journal-title":"Iran J Parasitol"},{"issue":"6","key":"14084_CR5","doi-asserted-by":"publisher","first-page":"e12906","DOI":"10.1111\/jeu.12906","volume":"69","author":"MM Usey","year":"2022","unstructured":"Usey MM, Huet D. Parasite powerhouse: A review of the Toxoplasma gondii mitochondrion. J Eukaryot Microbiol. 2022;69(6):e12906.","journal-title":"J Eukaryot Microbiol"},{"issue":"4","key":"14084_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26040819","volume":"26","author":"RM Shaapan","year":"2021","unstructured":"Shaapan RM, Al-Abodi HR, Alanazi AD, Shater AF, Mahmoudvand H. Myrtus communis essential oil; anti-parasitic effects and induction of the innate immune system in mice with toxoplasma gondii infection. Molecules. 2021;26(4):1\u20132.","journal-title":"Molecules"},{"issue":"8","key":"14084_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.heliyon.2023.e19295","volume":"9","author":"K Cheraghipour","year":"2023","unstructured":"Cheraghipour K, Khudair Khalaf A, Moradpour K, Mahmoudvand H, Marzban A. Synthesis, characterization, and antiparasitic effects of zinc oxide nanoparticles-eugenol nanosuspension against Toxoplasma gondii infection. Heliyon. 2023;9(8):1\u20138.","journal-title":"Heliyon"},{"key":"14084_CR8","doi-asserted-by":"crossref","unstructured":"Khairullah AR, Kurniawan SC, Widodo A, Effendi MH, Hasib A, Silaen OS, Ramandinianto SC, Moses IB, Riwu KH, Yanestria SM, Samodra ME. A comprehensive review of toxoplasmosis: serious threat to human health. Open Public Health J. 2024;17(1).","DOI":"10.2174\/0118749445281387240202094637"},{"key":"14084_CR9","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1017\/S0950268818002947","volume":"147","author":"SA Hosseini","year":"2019","unstructured":"Hosseini SA, Amouei A, Sharif M, Sarvi S, Galal L, Javidnia J, Pagheh AS, Gholami S, Mizani A, Daryani A. Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples. Epidemiol Infect. 2019;147:e36.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"14084_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1756-8722-5-63","volume":"5","author":"W Sun","year":"2012","unstructured":"Sun W. Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy. J Hematol Oncol. 2012;5(1):63.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"14084_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","volume":"17","author":"NS Vasudev","year":"2014","unstructured":"Vasudev NS, Reynolds AR. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis. 2014;17(3):471\u201394.","journal-title":"Angiogenesis"},{"issue":"2","key":"14084_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/bjc.2013.748","volume":"110","author":"T Nagasaki","year":"2014","unstructured":"Nagasaki T, Hara M, Nakanishi H, Takahashi H, Sato M, Takeyama H. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour\u2013stroma interaction. Br J Cancer. 2014;110(2):469\u201378.","journal-title":"Br J Cancer"},{"issue":"1","key":"14084_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1186\/s12879-025-11200-1","volume":"25","author":"A Poursalar","year":"2025","unstructured":"Poursalar A, Astaraki P, Khalaf AK, Baharvand P, Sepahvand A, Fallahi S, Mahmoudvand H. Epidemiological aspects and inflammatory cytokine profiles associated with Toxoplasma gondii infection in suicide attempters in Iran. BMC Infect Dis. 2025;25(1):834.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"14084_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12964-024-01822-4","volume":"22","author":"Y Xie","year":"2024","unstructured":"Xie Y, Wang J, Wang Y, Wen Y, Pu Y, Wang B. Parasite-enhanced immunotherapy: transforming the cold tumours to hot battlefields. Cell Communication Signal. 2024;22(1):448.","journal-title":"Cell Communication Signal"},{"issue":"13","key":"14084_CR15","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-12-1974","volume":"73","author":"JR Baird","year":"2013","unstructured":"Baird JR, Fox BA, Sanders KL, Lizotte PH, Cubillos-Ruiz JR, Scarlett UK, Rutkowski MR, Conejo-Garcia JR, Fiering S, Bzik DJ. Avirulent Toxoplasma gondii generates therapeutic antitumour immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Res. 2013;73(13):3842\u201351.","journal-title":"Cancer Res"},{"key":"14084_CR16","doi-asserted-by":"publisher","first-page":"2023004","DOI":"10.14411\/fp.2023.004","volume":"70","author":"R Kalantari","year":"2023","unstructured":"Kalantari R, Esmaeilifallah M, Jafari R, Mirhendi Esfahani H, Yousofi Darani H. A large-scale study on the seroprevalence of Toxoplasma gondii infection in humans in Iran. Folia Parasitol. 2023;70:2023004.","journal-title":"Folia Parasitol"},{"issue":"4","key":"14084_CR17","first-page":"443","volume":"17","author":"A Teimouri","year":"2022","unstructured":"Teimouri A, Goudarzi F, Goudarzi K, Alimi R, Sahebi K, Foroozand H, Keshavarz H. Toxoplasma gondii Infection in Immunocompromised Patients in Iran (2013\u20132022): A Systematic Review and Meta-Analysis. Iran J Parasitol. 2022;17(4):443\u201357.","journal-title":"Iran J Parasitol"},{"issue":"1","key":"14084_CR18","doi-asserted-by":"publisher","first-page":"2539482","DOI":"10.1155\/2020\/2539482","volume":"2020","author":"Y Yu","year":"2020","unstructured":"Yu Y, Guo D, Qu T, Zhao S, Xu C, Wang L, Wang Z, Fu H, Zhang X, Zhou N. Increased risk of Toxoplasma gondii infection in patients with colorectal cancer in eastern China: Seroprevalence, risk factors, and a case\u2013control study. Biomed Res Int. 2020;2020(1):2539482.","journal-title":"Biomed Res Int"},{"issue":"1","key":"14084_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12876-025-04144-y","volume":"25","author":"M Hataminejad","year":"2025","unstructured":"Hataminejad M, Basirpour B, Baharlou M, Gholami Koohestan M, Ziaei Hezarjaribi H, Rahimi Esboei B, Gholami S, Hosseini SA, Saberi R. Global prevalence and correlation of intestinal parasitic infections in patients with colorectal cancer: a systematic review and meta-analysis. BMC Gastroenterol. 2025;25(1):584.","journal-title":"BMC Gastroenterol"},{"key":"14084_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.micpath.2019.01.040","volume":"129","author":"D Anvari","year":"2019","unstructured":"Anvari D, Sharif M, Sarvi S, Aghayan SA, Gholami S, Pagheh AS, et al. Seroprevalence of Toxoplasma gondii infection in cancer patients: a systematic review and meta-analysis. Microb Pathog. 2019;129:30\u201342.","journal-title":"Microb Pathog"},{"issue":"12","key":"14084_CR21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39(12):1385\u201394.","journal-title":"Int J Parasitol"},{"issue":"6","key":"14084_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1550-7408.2008.00345.x","volume":"55","author":"JP Dubey","year":"2008","unstructured":"Dubey JP. The history of Toxoplasma gondii\u2014The first 100 years. J Eukaryot Microbiol. 2008;55(6):467\u201375.","journal-title":"J Eukaryot Microbiol"},{"issue":"4","key":"14084_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.11648\/j.ijcocr.20170204.13","volume":"2","author":"DF Ahmed","year":"2017","unstructured":"Ahmed DF, Entsar Jabbar Saheb. The Association of Toxoplasma gondii Infection in Breast and Colorectal Cancer Patients. Int J Clin Oncol Cancer Res. 2017;2(4):86\u201392. https:\/\/doi.org\/10.11648\/j.ijcocr.20170204.13.","journal-title":"Int J Clin Oncol Cancer Res"},{"issue":"10","key":"14084_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrc909","volume":"2","author":"N Ferrara","year":"2002","unstructured":"Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002;2(10):795\u2013803.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"14084_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc2403","volume":"8","author":"LM Ellis","year":"2008","unstructured":"2, Ellis LM, Hicklin DJ. VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer. 2008;8(8):579\u201391.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"14084_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nri3598","volume":"14","author":"F Yarovinsky","year":"2014","unstructured":"Yarovinsky F. Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol. 2014;14(2):109\u201321.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"14084_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"issue":"2","key":"14084_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00384-009-0818-8","volume":"25","author":"H Kn\u00fcpfer","year":"2010","unstructured":"Kn\u00fcpfer H, Preiss R. Serum interleukin-6 levels in colorectal cancer patients\u2014A summary of published results. Int J Colorectal Dis. 2010;25(2):135\u201340.","journal-title":"Int J Colorectal Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14084-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:02:01Z","timestamp":1792782121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14084-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14084"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14084-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patient recruitment was conducted in accordance with the ethical guidelines outlined in the 1964 Helsinki Declaration. Written informed consent was obtained from all participants, as well as from the legal guardians of participants who were illiterate. Furthermore, the study protocol was approved by the Ethics Committee of Lorestan University of Medical Sciences, Khorrambad, Iran (Approval No. IR.LUMS.1404.380).","order":1,"name":"Ethics","label":"Ethical considerations and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1870"}}